$51.28-0.68 (-1.31%)
Zurn Elkay Water Solutions Corporation engages in design, procurement, manufacture, and marketing of water management solutions in the United States, Canada, and internationally.
Zurn Elkay Water Solutions Corporation in the Industrials sector is trading at $51.28. The stock is currently near its 52-week high of $53.76, remaining 10.0% above its 200-day moving average. Technical signals show neutral RSI of 56 and bullish MACD crossover, explaining why ZWS maintains its current momentum and trend strength. The Whystock Score of 85/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Zurn Elkay Water Solutions Corporation engages in design, procurement, manufacture, and marketing of water management solutions in the United States, Canada, and internationally. It offers water dispensing and filtration products, such as filtered bo...
Zurn Elkay’s first-quarter results were well received by the market, as management credited gains in core product categories and progress on operational initiatives. CEO Todd Adams pointed to the company’s “11% organic sales growth” and highlighted that growth in water safety, control, and drinking water products outpaced other areas. Additionally, the company’s focus on higher-margin offerings and ongoing improvements in its supply chain were cited as key contributors to the quarter’s profitabi
Does Zurn Water (ZWS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zurn Elkay Water Solutions Cor (NYSE:ZWS) opened fiscal 2026 with double-digit organic growth and expanding profitability, as executives pointed to solid execution on internal initiatives, favorable product mix, and continued confidence in the company’s ability to manage a changing tariff landscape.
While Zurn Elkay Water Solutions Corporation ( NYSE:ZWS ) might not have the largest market cap around , it received a...
Water management solutions company Zurn Elkay (NYSE:ZWS) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 11.4% year on year to $433 million. Its non-GAAP profit of $0.41 per share was 13% above analysts’ consensus estimates.